Gapping down
In reaction to disappointing earnings/guidance:
- RRGB -24.1%, EXAS -21.8%, AXGN -20.1%, IO -15.4%, TRIP -11.8%, W -11.3%, MZOR -11.2%, FND -10.9%, AVP -8%, EPZM -7.7%, RRD -7.5%, SBH -7.3%, TEVA -7.3%, PPC -6.5%, TS -6.4%, LPSN -5.8%, CTSH -5.5%, WLK -5.1%, MRC -5%, MRNS -5%, HUBS -4.8%, WYNN -4.8%, TTEK -4.8%, CCRN -4.4%, MGM -4.4%, FEYE -4.2%, ARRS -4%, QRVO -3.9%, HFC -3.8%, TAHO -3.7%, AR -3.3%, YUMC -3.3%, CLVS -3.3%, APRN -3.3%, SQ -3.2%, YUM -3.1%, CECO -2.9%, FMC -2.6%, EPAM -2.4%, EXK -2.4%, BLUE -2.3%, LPI -2.2%, HYGS -2.2%, MD -2.1%, WRK -2%, OBE -1.9%, CXO -1.8%, CDXC -1.8%, HSC -1.8%, APU -1.6%, CRUS -1.6%, ING -1.5%, ICE -1.5%, XPO -1.4% (also CFO John Hardig to step down August 15, 2018), APA -1.3%, DUK -1.3%, RFP -1.3%, LHCG -1.1%, SRI -1.1%, CDW -1.1%, PRU -1%, MRO -1%, GPOR -1%, CRIS -1%, SPAR -1%
Other news:
- ADMP -7.6% (announces proposed public offering of common stock), I -2.8% (announces proposed offering of $1.0 bln aggregate principal amount of senior notes due 2023)
- MLCO -1.5% (following WYNN results)
- TXMD -1.5% (prices $65 mln public offering of common stock at a price to the public of $5.10 per share)
Analyst comments:
- IQ -3.1% (downgraded to Neutral from Buy at Goldman)
- RDS.A -1.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- HBI -1.3% (downgraded to Equal Weight from Overweight at Barclays)
- BG -0.9% (downgraded to Neutral from Overweight at JP Morgan)
- FL -0.9% (initiated with Underweight at Morgan Stanley)
![]()